Similar articles

• Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.

  Köstler WJ, Brodowicz T, Zielinski CC; Central European Cooperative Oncology Group (CECOG). Köstler WJ, et al. J Natl Cancer Inst. 2010 Feb 3;102(3):207; author reply 207-8. doi: 10.1093/jnci/djp483. Epub 2010 Jan 6. J Natl Cancer Inst. 2010. PMID: 20054016 No abstract available.
• [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].

  Pérez JE, Machiavelli M, Romero A, Leone BA, Rabinovich MG, Arévalo E. Pérez JE, et al. Medicina (B Aires). 1982;42(6 Pt 1):587-95. Medicina (B Aires). 1982. PMID: 6897849 Spanish. No abstract available.
• Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.

  Smalley RV, Murphy S, Huguley CM Jr, Bartolucci AA. Smalley RV, et al. Cancer Res. 1976 Nov;36(11 Pt 1):3911-6. Cancer Res. 1976. PMID: 975039 Clinical Trial.
• Chemotherapy for breast cancer.

  Sarg MJ Jr. Sarg MJ Jr. J Reprod Med. 1979 Jul;23(1):3-11. J Reprod Med. 1979. PMID: 226698 Review. No abstract available.
• [CMF or CAF combination chemotherapy for breast cancer].

  Ota J. Ota J. Gan To Kagaku Ryoho. 1996 Dec;23(14):1886-90. Gan To Kagaku Ryoho. 1996. PMID: 8978791 Review. Japanese.